Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07657182 · ClinicalTrials.gov registry record · Phase 4
A Prospective, Randomized, Assessor-Blinded, Multicenter Study Comparing Avance Nerve Graft and Autograft for Functional Recovery Following Mixed and Motor Peripheral Nerve Reconstruction
A Phase 4 study, sponsored by Axogen Corporation.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 178
- Enrollment target
NCT07657182 is a Phase 4 study that is actively recruiting participants, run by Axogen Corporation. The registered enrollment target is 178 participants.
The verdict
NCT07657182, a Phase 4 study, is actively recruiting participants, sponsored by Axogen Corporation.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 178 participants
- Enrollment target
Study Summary
This is a multicenter, 1:1 randomized, prospective, comparative study in participants requiring reconstruction of a mixed or motor nerve in the upper extremity. This study will consist of a screening visit, an operative visit, and 9 post-operative follow-up visits at Week 4, and Months 3, 6, 9, 12, 15, 18, 21, and 24.
Interventions
- BIOLOGICAL Avance Nerve Graft
- PROCEDURE Sural nerve autograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2026-06-12 |
| Est. Completion | 2030-12-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07657182
The ClinicalTrials.gov registry entry for NCT07657182 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Axogen Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Avance Nerve Graft is the first listed.
NCT07657182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07657182 about?
NCT07657182 is a clinical study titled "A Prospective, Randomized, Assessor-Blinded, Multicenter Study Comparing Avance Nerve Graft and Autograft for Functional Recovery Following Mixed and Motor Peripheral Nerve Reconstruction". This is a multicenter, 1:1 randomized, prospective, comparative study in participants requiring reconstruction of a mixed or motor nerve in the upper extremity. This study will consist of a screening visit, an operative visit, and 9 post-operative follow-up visits at Week 4, and Months 3, 6, 9, 12, ...
What is the current status of trial NCT07657182?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 178 participants. The study started on 2026-06-12. Estimated completion is 2030-12-05.
What interventions are being tested in trial NCT07657182?
The interventions under investigation include: Avance Nerve Graft (BIOLOGICAL), Sural nerve autograft (PROCEDURE).
Who is sponsoring clinical trial NCT07657182?
This trial is sponsored by Axogen Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.